phrykt

BioNTech SE (BNTX): who owns it and who trades it

As of Nov 16, 2026, BNTX insiders reported 27 open-market sales worth $89.8M and no purchases in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Ugur Sahin (CEO), with $84.2M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling BioNTech

From the latest filings

Overall: more buying than selling. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns BNTX

282 funds and institutions reported BNTX shares worth $4.4B at the end of Q2 2026, about 19% of the company. The largest holder is FMR LLC (Fidelity) with 3.0%.

Funds and institutions (13F) 19%Everyone else 81%

10 largest owners, by share of the company

FMR LLC (Fidelity)3.0%
Primecap Management Co1.5%
Dodge & Cox1.5%
Flossbach Von Storch Se0.9%
T. Rowe Price Investment Management, Inc.0.8%
BlackRock, Inc.0.7%
Temasek Holdings (Private) Ltd0.6%
BNP Paribas Financial Markets0.5%
Logos Global Management LP0.4%
GSK plc0.4%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FMR LLC (Fidelity)7.57M3.01%$705M+33%
Primecap Management Co3.77M1.50%$351M-1%
Dodge & Cox3.68M1.46%$342MNo change
Flossbach Von Storch Se2.23M0.89%$207M-40%
T. Rowe Price Investment Management, Inc.2.07M0.82%$192M-65%
BlackRock, Inc.1.85M0.74%$173M+12%
Temasek Holdings (Private) Ltd1.51M0.60%$140MNo change
BNP Paribas Financial Markets1.32M0.53%$123M-20%
Logos Global Management LP1.01M0.40%$94.4M–
GSK plc889,8240.35%$82.8MNo change
Assenagon Asset Management S.A.846,5260.34%$78.8M–
First Trust Advisors LP791,4690.32%$73.6M-6%
Davern Capital Partners, LP754,5500.30%$70.2M+147%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC744,2000.30%$69.2M-5%
Massachusetts Financial Services Co677,7080.27%$63.1M+1%
Long Focus Capital Management, LLC624,0000.25%$58.1MNo change
Baillie Gifford & Co592,3800.24%$55.1M-33%
Goldman Sachs Group Inc589,9030.23%$54.9M+509%
Victory Capital Management Inc539,7870.21%$50.2M+13%
Franklin Resources Inc539,5930.21%$50.2M+40%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, BNTX insiders reported $0 of open-market purchases and $89.8M of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$89.8M
27 trades, 2 people
Sales under a 10b5-1 plan
100%
Share of sale value
Latest trade
Oct 9, 2026
Filed Oct 9, 2026

Purchases and sales by month

$63.7M$63.7MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 9, 2026Ugur SahinCEOSale plan36,209$95.37$3.5MForm 4
Oct 8, 2026Ugur SahinCEOSale plan27,000$92.31$2.5MForm 4
Oct 7, 2026Ugur SahinCEOSale plan24,000$95.86$2.3MForm 4
Oct 6, 2026Ugur SahinCEOSale plan21,000$96.81$2MForm 4
Oct 5, 2026Ugur SahinCEOSale plan72,000$97.23$7MForm 4
Oct 2, 2026Ugur SahinCEOSale plan17,000$96.72$1.6MForm 4
Oct 1, 2026Ugur SahinCEOSale plan17,000$97.46$1.7MForm 4
Sep 30, 2026Ugur SahinCEOSale plan32,000$98.12$3.1MForm 4
Sep 29, 2026Ugur SahinCEOSale plan34,000$98.26$3.3MForm 4
Sep 28, 2026Ugur SahinCEOSale plan34,000$98.47$3.3MForm 4
Sep 25, 2026Ugur SahinCEOSale plan27,000$98.69$2.7MForm 4
Sep 24, 2026Ugur SahinCEOSale plan39,000$98.99$3.9MForm 4
Sep 23, 2026Ugur SahinCEOSale plan30,000$99.40$3MForm 4
Sep 22, 2026Ugur SahinCEOSale plan46,000$100.72$4.6MForm 4
Sep 21, 2026Ugur SahinCEOSale plan33,000$97.81$3.2MForm 4
Sep 18, 2026Ugur SahinCEOSale plan30,000$96.22$2.9MForm 4
Sep 17, 2026Ugur SahinCEOSale plan34,000$98.60$3.4MForm 4
Sep 16, 2026Ugur SahinCEOSale plan15,000$96.09$1.4MForm 4
Sep 15, 2026Ugur SahinCEOSale plan34,000$96.49$3.3MForm 4
Sep 14, 2026Ugur SahinCEOSale plan41,000$99.45$4.1MForm 4
Sep 11, 2026Ugur SahinCEOSale plan45,000$96.93$4.4MForm 4
Sep 10, 2026Ugur SahinCEOSale plan20,500$96.31$2MForm 4
Sep 9, 2026Ugur SahinCEOSale plan36,000$97.78$3.5MForm 4
Sep 8, 2026Ugur SahinCEOSale plan37,000$99.20$3.7MForm 4
Sep 4, 2026Ugur SahinCEOSale plan31,500$103.52$3.3MForm 4
Sep 3, 2026Ugur SahinCEOSale plan45,000$102.85$4.6MForm 4
Apr 22, 2026Sierk PoettingChief Operating OfficerSale plan50,000$110.56$5.5MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Ugur SahinChief Executive Officer, 10% owner–$84.2MOct 9, 2026
Sierk PoettingChief Operating Officer–$5.5MApr 22, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BNTX short interest

2.25M BNTX shares are sold short. Over the last 12 reports the number of shares short went down 8%.

As of Oct 30, 2026, 2.25M BNTX shares were sold short, down 1.2% from the report before. At the average daily volume of 1.04M shares, buying them all back would take about 2.1 trading days (days to cover).

Shares short, % of all shares

0.99%May 15Sep 301.12%

Days to cover

2.1May 15Oct 303.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20262.25M–-1%1.04M2.1
Oct 15, 20262.27M–-9%1.11M2.1
Sep 30, 20262.50M0.99%+7%799,0433.1
Sep 15, 20262.32M0.92%+1%895,2582.6
Aug 31, 20262.30M0.92%-8%2.35M1.0
Aug 14, 20262.51M1.00%+2%1.08M2.3
Jul 31, 20262.47M0.98%+9%750,9603.3
Jul 15, 20262.27M0.90%-2%780,2582.9
Jun 30, 20262.32M0.93%-15%834,8922.8
Jun 15, 20262.74M1.09%+21%1.17M2.3
May 29, 20262.26M0.90%-8%948,5162.4
May 15, 20262.45M0.98%+11%942,8832.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded BNTX

Since Nov 17, 2024, 1 member of Congress reported 0 purchases and 1 sale of BNTX. The latest was a sale by Val T. Hoyle on Aug 7, 2025, reported Sep 12, 2025.

Purchases 0Sales 1

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Aug 7, 2025Val T. Hoyle (D-OR)Sale$1K–$15KSpouseSep 12, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Famous investors that hold BNTX

5 of the 50 well-known investors we track reported holding BNTX in their latest 13F filing. The largest position is Israel Englander's, worth $62.7M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026637,768$62.7M0.0%New
Ken Griffin · Citadel AdvisorsQ3 2026572,754$56.3M0.0%+57%
Steve Cohen · Point72 Asset ManagementQ3 2026419,418$41.2M0.1%+28%
Paul Tudor Jones · Tudor Investment CorpQ3 20263,174$312K0.0%New
Cathie Wood · ARK Investment ManagementQ3 20262$2370.0%-100%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about BioNTech SE (BNTX) stock

Who owns the most BNTX stock?

The largest reported owner of BioNTech SE (BNTX) is FMR LLC (Fidelity), with 3.0% of the company. In total, 282 funds and institutions reported holding BNTX at the end of Q2 2026, together about 19% of the shares. See the largest owners.

Are BNTX insiders buying or selling?

In the last 12 months, BNTX insiders reported no open-market purchases and 27 sales worth $89.8M. The latest trade was on Oct 9, 2026. See every trade.

What is the short interest in BNTX?

As of Oct 30, 2026, 2.25M BNTX shares were sold short, down 1.2% from the report before. At the average daily volume of 1.04M shares, buying them all back would take about 2.1 trading days (days to cover). See the history.

Have members of Congress traded BNTX?

Yes. 1 member of Congress reported 0 purchases and 1 sale of BNTX since Nov 17, 2024. The latest was reported on Sep 12, 2025. See the trades.

Which famous investors hold BNTX?

5 of the 50 well-known investors we track reported BNTX in their latest 13F filing, including Israel Englander, Ken Griffin, Steve Cohen. The largest position is worth $62.7M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.